Zobrazeno 1 - 10
of 42
pro vyhledávání: '"G. Caleb Alexander"'
Autor:
Alexander R. Zheutlin, Nasser Sharareh, Jenny S. Guadamuz, Ransmond O. Berchie, Catherine G. Derington, Joshua A. Jacobs, Favel L. Mondesir, G. Caleb Alexander, Emily B. Levitan, Monika Safford, Robert O. Vos, Dima M. Qato, Adam P. Bress
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 5 (2024)
Background Poor neighborhood‐level access to health care, including community pharmacies, contributes to cardiovascular disparities in the United States. The authors quantified the association between pharmacy proximity, antihypertensive and statin
Externí odkaz:
https://doaj.org/article/b9b50bd1dca2489399c69580e1c71e23
Autor:
Rishav Adhikari, Kunal Jha, Zeina Dardari, James Heyward, Roger S. Blumenthal, Robert H. Eckel, G. Caleb Alexander, Michael J. Blaha
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 9 (2022)
Background Sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) and glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) mitigate cardiovascular risk in individuals with type 2 diabetes, but most eligible patients do not receive them. We cha
Externí odkaz:
https://doaj.org/article/54e819014e4549dc8a35d0dce0097b46
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 1, Pp 153-162 (2021)
Many academic institutions are collecting blood samples from patients seeking treatment for coronavirus disease 2019 (COVID‐19) to build research biorepositories. It may be feasible to extract pharmacogenomic (PGx) information from biorepositories
Externí odkaz:
https://doaj.org/article/5a191755a9304d1899e4870a5abe9bb3
Autor:
Xiaoxi Yao, Neena S. Abraham, G. Caleb Alexander, William Crown, Victor M. Montori, Lindsey R. Sangaralingham, Bernard J. Gersh, Nilay D. Shah, Peter A. Noseworthy
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 2 (2016)
BackgroundIn comparison to warfarin, non–vitamin K antagonist oral anticoagulants (NOACs) have the advantages of ease of dosing, fewer drug interactions, and lack of need for ongoing monitoring. We sought to evaluate whether these advantages transl
Externí odkaz:
https://doaj.org/article/103c1875741242478c5c107b71d750f1
Publikováno v:
Allergy. 78:1116-1119
Publikováno v:
Pharmacoepidemiology and Drug Safety. 31:1027-1038
Many commonly used prescription medications have cardiovascular adverse effects, yet the cumulative risk of cardiovascular events associated with the concurrent use of these medications is unknown. We examined the association between the concurrent u
Autor:
Shirin Ardeshirrouhanifard, Huijun An, Ravi K. Goyal, Mukaila A. Raji, Jodi B. Segal, G. Caleb Alexander, Hemalkumar B. Mehta
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 42:375-386
Anticoagulation among patients with cancer and atrial fibrillation is challenging due to elevated risk of bleeding and stroke. We characterized use of oral anticoagulants among patients with cancer and non-valvular atrial fibrillation (NVAF).We used
Publikováno v:
Journal of the American Geriatrics Society. 70:1685-1694
Publikováno v:
Addiction. 117:969-976
BACKGROUND AND AIMS Despite prescribing declines between 2011 and 2019, opioid morbidity and mortality in the United States continued to rise during this period. We estimated the relationship between opioid prescribing, opioid use disorder (OUD) and
Publikováno v:
Journal of the American Geriatrics Society. 70:1883-1885